Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
307.00
251.00
456.00
262.00
139.00
166.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
307.00
251.00
456.00
262.00
139.00
166.00
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-3.00
-2.00
0.00
-5.00
5.00
Raw Materials Consumed
154.00
113.00
203.00
165.00
92.00
114.00
Power & Fuel Cost
17.00
12.00
11.00
6.00
4.00
3.00
Employee Cost
32.00
29.00
20.00
15.00
11.00
8.00
Operating Expenses
6.00
5.00
4.00
3.00
2.00
2.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
7.00
12.00
27.00
24.00
9.00
9.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
2.00
1.00
0.00
1.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
240.00
190.00
284.00
233.00
125.00
150.00
Operating Profit (PBDIT) excl Other Income
66.00
60.00
171.00
28.00
14.00
15.00
Other Income
1.00
2.00
3.00
1.00
3.00
0.00
Operating Profit (PBDIT)
68.00
63.00
175.00
30.00
17.00
16.00
Interest
10.00
6.00
2.00
2.00
2.00
2.00
Profit before Depriciation and Tax
57.00
57.00
172.00
27.00
15.00
14.00
Depreciation
19.00
14.00
10.00
6.00
4.00
3.00
Profit Before Taxation & Exceptional Items
38.00
42.00
161.00
21.00
10.00
10.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
31.00
25.00
161.00
21.00
10.00
10.00
Provision for Tax
7.00
6.00
41.00
6.00
2.00
3.00
Profit After Tax
23.00
19.00
119.00
14.00
8.00
7.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
179.00
160.00
42.00
26.00
17.00
10.00
Profit Available for appropriations
203.00
179.00
162.00
41.00
25.00
17.00
Appropriations
203.00
179.00
162.00
41.00
25.00
17.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
22.76
18.16
115.12
14.60
8.02
7.28
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 22.36% vs -44.97% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 9.20% vs -64.62% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 57.19% vs 126.50% in Mar 2023
Profit After Tax
YoY Growth in year ended Mar 2024 is 22.49% vs -83.93% in Mar 2023
Compare Profit and Loss Results of Kwality Pharma
Figures in Rs cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
307.00
10,334.00
-10,027.00
-97.03%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
307.00
10,334.00
-10,027.00
-97.03%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-94.00
93.00
98.94%
Raw Materials Consumed
154.00
3,263.00
-3,109.00
-95.28%
Power & Fuel Cost
17.00
129.00
-112.00
-86.82%
Employee Cost
32.00
2,274.00
-2,242.00
-98.59%
Operating Expenses
6.00
210.00
-204.00
-97.14%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
7.00
928.00
-921.00
-99.25%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
134.00
-132.00
-98.51%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
240.00
7,798.00
-7,558.00
-96.92%
Operating Profit (PBDIT) excl Other Income
66.00
2,536.00
-2,470.00
-97.40%
Other Income
1.00
280.00
-279.00
-99.64%
Operating Profit (PBDIT)
68.00
2,817.00
-2,749.00
-97.59%
Interest
10.00
35.00
-25.00
-71.43%
Profit before Depriciation and Tax
57.00
2,782.00
-2,725.00
-97.95%
Depreciation
19.00
398.00
-379.00
-95.23%
Profit Before Taxation & Exceptional Items
38.00
2,384.00
-2,346.00
-98.41%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
31.00
2,399.00
-2,368.00
-98.71%
Provision for Tax
7.00
457.00
-450.00
-98.47%
Profit After Tax
23.00
1,926.00
-1,903.00
-98.81%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
179.00
8,012.00
-7,833.00
-97.77%
Profit Available for appropriations
203.00
9,925.00
-9,722.00
-97.95%
Appropriations
203.00
9,925.00
-9,722.00
-97.95%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
22.76
47.75
-24.99
-52.34%
Profit And Loss - Net Sales
Net Sales 307.17 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 22.36% vs -44.97% in Mar 2023
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 66.31 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 9.20% vs -64.62% in Mar 2023
Profit And Loss - Interest
Interest 10.39 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 57.19% vs 126.50% in Mar 2023
Profit And Loss - Profit After Tax
Profit After Tax 23.62 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 22.49% vs -83.93% in Mar 2023